BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28558075)

  • 1. A never-ending story: the steadily growing family of the FA and FA-like genes.
    Gueiderikh A; Rosselli F; Neto JBC
    Genet Mol Biol; 2017; 40(2):398-407. PubMed ID: 28558075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.
    Bhattacharjee S; Nandi S
    Cell Commun Signal; 2017 Oct; 15(1):41. PubMed ID: 29017571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.
    Cheung RS; Taniguchi T
    Int J Hematol; 2017 Sep; 106(3):335-344. PubMed ID: 28631178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination.
    Inano S; Sato K; Katsuki Y; Kobayashi W; Tanaka H; Nakajima K; Nakada S; Miyoshi H; Knies K; Takaori-Kondo A; Schindler D; Ishiai M; Kurumizaka H; Takata M
    Mol Cell; 2017 Jun; 66(5):622-634.e8. PubMed ID: 28575658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RPA-Mediated Recruitment of the E3 Ligase RFWD3 Is Vital for Interstrand Crosslink Repair and Human Health.
    Feeney L; Muñoz IM; Lachaud C; Toth R; Appleton PL; Schindler D; Rouse J
    Mol Cell; 2017 Jun; 66(5):610-621.e4. PubMed ID: 28575657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks.
    Abdullah UB; McGouran JF; Brolih S; Ptchelkine D; El-Sagheer AH; Brown T; McHugh PJ
    EMBO J; 2017 Jul; 36(14):2047-2060. PubMed ID: 28607004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.
    Knies K; Inano S; Ramírez MJ; Ishiai M; Surrallés J; Takata M; Schindler D
    J Clin Invest; 2017 Aug; 127(8):3013-3027. PubMed ID: 28691929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia.
    Bogliolo M; Bluteau D; Lespinasse J; Pujol R; Vasquez N; d'Enghien CD; Stoppa-Lyonnet D; Leblanc T; Soulier J; Surrallés J
    Genet Med; 2018 Apr; 20(4):458-463. PubMed ID: 28837157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging functions of the Fanconi anemia pathway at a glance.
    Sumpter R; Levine B
    J Cell Sci; 2017 Aug; 130(16):2657-2662. PubMed ID: 28811338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination-Linked Phosphorylation of the FANCI S/TQ Cluster Contributes to Activation of the Fanconi Anemia I/D2 Complex.
    Cheung RS; Castella M; Abeyta A; Gafken PR; Tucker N; Taniguchi T
    Cell Rep; 2017 Jun; 19(12):2432-2440. PubMed ID: 28636932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional relationships of FAN1.
    Jin H; Cho Y
    DNA Repair (Amst); 2017 Aug; 56():135-143. PubMed ID: 28623094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
    Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
    Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways.
    Su WP; Ho YC; Wu CK; Hsu SH; Shiu JL; Huang JC; Chang SB; Chiu WT; Hung JJ; Liu TL; Wu WS; Wu PY; Su WC; Chang JY; Liaw H
    Sci Rep; 2017 Jun; 7(1):3879. PubMed ID: 28634400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders.
    Walsh MF; Chang VY; Kohlmann WK; Scott HS; Cunniff C; Bourdeaut F; Molenaar JJ; Porter CC; Sandlund JT; Plon SE; Wang LL; Savage SA
    Clin Cancer Res; 2017 Jun; 23(11):e23-e31. PubMed ID: 28572264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
    Pawlikowska P; Delestré L; Gregoricchio S; Oppezzo A; Esposito M; Diop MB; Rosselli F; Guillouf C
    Oncogene; 2023 Sep; 42(37):2764-2775. PubMed ID: 37573408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fanca deficiency is associated with alterations in osteoclastogenesis that are rescued by TNFα.
    Oppezzo A; Monney L; Kilian H; Slimani L; Maczkowiak-Chartois F; Rosselli F
    Cell Biosci; 2023 Jun; 13(1):115. PubMed ID: 37355617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in AcrR and RNA Polymerase Confer High-Level Resistance to Psoralen-UVA Irradiation.
    Worley TK; Weber EA; Acott JD; Shimpi RS; Cole JM; Courcelle CT; Courcelle J
    J Bacteriol; 2023 Jun; 205(6):e0012623. PubMed ID: 37249472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safeguarding DNA Replication: A Golden Touch of MiDAS and Other Mechanisms.
    Al Ahmad Nachar B; Rosselli F
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution.
    Chang L; Cui Z; Shi D; Chu Y; Wang B; Wan Y; Ma Q; Zhang R; Li H; Cheng X; Cheng T; Zhu X; Li C; Yuan W
    Exp Hematol Oncol; 2022 Sep; 11(1):64. PubMed ID: 36167633
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.